gp120 antibody
gp120 Antibody |
|||
4641-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
4641-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
24700-100ul | SAB | 100ul | 468 EUR |
gp120 Antibody |
|||
24745-100ul | SAB | 100ul | 468 EUR |
gp120 Antibody |
|||
8677-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
8677-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
HIV1 gp120 antibody |
|||
20R-2834 | Fitzgerald | 100 ul | 975.6 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000401 | Fitzgerald | 500 ul | 812.4 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000401F | Fitzgerald | 500 ul | 492 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000402 | Fitzgerald | 100 ug | 210 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-HG81 | Fitzgerald | 1 mg | 376.8 EUR |
Description: Goat polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20C-CR2102RP | Fitzgerald | 100 ug | 826.8 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
10-2771 | Fitzgerald | 100 ug | 404.4 EUR |
Description: Monoclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
10-H30M | Fitzgerald | 100 ug | 333.6 EUR |
Description: Mouse monoclonal HIV1 gp120 antibody |
|||
gp120 Peptide |
|||
4777P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) gp120 peptide |
|||
gp120 Peptide |
|||
4641P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) gp120 peptide |
|||
gp120 Peptide |
|||
8677P | ProSci | 0.05 mg | 197.7 EUR |
Description: gp120 Peptide |
|||
HIV1 gp120 antibody (FITC) |
|||
60-00402-3 | Fitzgerald | 50 ug | 201.6 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody (FITC) conjugated |
|||
HIV1 gp120 antibody (biotin) |
|||
60-00402-5 | Fitzgerald | 50 ug | 543.6 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody (biotin) conjugated |
|||
HIV1 gp120 antibody (HRP) |
|||
60-H14 | Fitzgerald | 1 ml | 490.8 EUR |
Description: Goat polyclonal HIV1 gp120 antibody (HRP) conjugated |
|||
HIV1 gp120 antibody (biotin) |
|||
60C-CR1248GB | Fitzgerald | 1 ml | 544.8 EUR |
Description: Goat polyclonal HIV1 gp120 antibody (biotin) conjugated |
|||
HIV1 gp120 antibody (HRP) |
|||
61-001002 | Fitzgerald | 50 ug | 159.6 EUR |
Description: Mouse monoclonal HIV1 gp120 antibody (HRP) |
|||
HIV1 gp120 antibody (biotin) |
|||
61-001005 | Fitzgerald | 50 ug | 483.6 EUR |
Description: Mouse monoclonal HIV1 gp120 protein (biotin) |
|||
SIV mac251 gp120 antibody |
|||
20-000111 | Fitzgerald | 500 ul | 476.4 EUR |
Description: Rabbit polyclonal SIV mac251 gp120 antibody |
|||
SIV mac251 gp120 antibody |
|||
20-000112 | Fitzgerald | 100 ug | 386.4 EUR |
Description: Rabbit polyclonal SIV mac251 gp120 antibody |
|||
SIV macC251 gp120 antibody |
|||
10R-S109a | Fitzgerald | 100 ug | 716.4 EUR |
Description: Mouse monoclonal SIV macC251, gp120 antibody |
|||
HIV-1 gp120 Antibody |
|||
20-abx137103 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
20-abx137183 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
20-abx137505 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
abx023024-1ml | Abbexa | 1 ml | 777.6 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
abx411417-1ml | Abbexa | 1 ml | 610.8 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
abx412175-1mg | Abbexa | 1 mg | 610.8 EUR |
HIV1 gp120 protein |
|||
30-12001-2 | Fitzgerald | 100 ug | 846 EUR |
Description: Purified recombinant HIV1 gp120 protein |
|||
HIV1 gp120 protein |
|||
30-12001-4 | Fitzgerald | 1 mg | 7546.8 EUR |
Description: Purified recombinant HIV1 gp120 protein (HRP) |
|||
HIV1 gp120 protein |
|||
30-AH86 | Fitzgerald | 100 ug | 1585.2 EUR |
Description: Purified full length recombinant HIV1 gp120 protein-IIIB strain |
|||
GP120 Recombinant Protein |
|||
96-365 | ProSci | 0.1 mg | 619.8 EUR |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
|||
GP120 Recombinant Protein |
|||
96-366 | ProSci | 0.1 mg | 619.8 EUR |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
|||
GP120 Recombinant Protein |
|||
96-367 | ProSci | 0.1 mg | 714.3 EUR |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
|||
HIV-1 gp120 |
|||
E62H004 | EnoGene | 100ug | 458.4 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (Biotin) |
|||
abx411418-1ml | Abbexa | 1 ml | 710.4 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (HRP) |
|||
abx411419-1ml | Abbexa | 1 ml | 760.8 EUR |
SIV mac251 gp120 antibody (FITC) |
|||
60-00112-3 | Fitzgerald | 50 ug | 159.6 EUR |
Description: Rabbit polyclonal SIV mac251 gp120 antibody (FITC) |
|||
SIV mac251 gp120 antibody (biotin) |
|||
60-00112-5 | Fitzgerald | 50 ug | 489.6 EUR |
Description: Rabbit polyclonal SIV gp 120 antibody (biotin) |
|||
HIV-1 gp120 Antibody (Biotin) |
|||
abx023022-1ml | Abbexa | 1 ml | 718.8 EUR |
HIV-1 gp120 Antibody (HRP) |
|||
abx023023-1ml | Abbexa | 1 ml | 794.4 EUR |
gp120, HIV-1 MN |
|||
5-01248 | CHI Scientific | 4 x 1mg | Ask for price |
HIV-gp120-41-C |
|||
5-01323 | CHI Scientific | 4 x 1mg | Ask for price |
HIV -gp120- Antigenic Peptide |
|||
5-01326 | CHI Scientific | 4 x 1mg | Ask for price |
HIV (gp120) Antigenic Peptide |
|||
H-2982.0500 | Bachem | 0.5mg | 486 EUR |
Description: Sum Formula: C117H211N41O31S; CAS# [198636-94-1] net |
|||
HIV (gp120) Antigenic Peptide |
|||
H-2982.1000 | Bachem | 1.0mg | 849.6 EUR |
Description: Sum Formula: C117H211N41O31S; CAS# [198636-94-1] net |
|||
HIV-gp120-41-C |
|||
SP-100306-1 | Alpha Diagnostics | 1 mg | 196.8 EUR |
Mouse antibody for HIV-1 gp120 |
|||
1996 | Virostat | 100 ug | 425.4 EUR |
Description: This is purified Mouse monoclonal antibody against HIV-1 gp120 for WB, ELISA. |
|||
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
DPAB0252 | Creative Diagnostics | 1 ml | 889.2 EUR |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
DPAB0253 | Creative Diagnostics | 1 ml | 937.2 EUR |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
DPAB0254 | Creative Diagnostics | 1 ml | 999.6 EUR |
HIV-gp120-41-N-A |
|||
5-01324 | CHI Scientific | 4 x 1mg | Ask for price |
HIV-gp120-41-N-B |
|||
5-01325 | CHI Scientific | 4 x 1mg | Ask for price |
HIV -gp120- Fragment (254-274) |
|||
5-01327 | CHI Scientific | 4 x 1mg | Ask for price |
HIV-gp120- Fragment (308-331) |
|||
5-01328 | CHI Scientific | 4 x 1mg | Ask for price |
HIV-gp120-Fragment (318-327) |
|||
5-01329 | CHI Scientific | 4 x 5mg | Ask for price |